The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.

The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

The global self-testing market share analysis is on track to reach USD 8,855.3 million by 2025, driven by increasing consumer demand for at-home diagnostic solutions, digital monitoring devices, and a ...

The Business Research Company The Business Research Company's Vitamin Biomarkers Global Market Report 2025 – Market Size, Trends, And Forec ...

Fluorescence in situ hybridization (FISH) is a diagnostic test that maps genetic material within human cells, identifying specific genes or segments. Due to its ability to detect genetic mutations ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

The Network Lead of Anglo West Africa at Roche Diagnostics, Mr Roberto Taboada, has called on the Federal Government to increase investment in Human Papillomavirus, noting that HPV is the second ...